000 01714 a2200457 4500
005 20250514052041.0
264 0 _c20021224
008 200212s 0 0 eng d
022 _a0022-3565
024 7 _a10.1124/jpet.102.040618
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAnderson, Jeffery J
245 0 0 _a[3H]Methoxymethyl-3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine binding to metabotropic glutamate receptor subtype 5 in rodent brain: in vitro and in vivo characterization.
_h[electronic resource]
260 _bThe Journal of pharmacology and experimental therapeutics
_cDec 2002
300 _a1044-51 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article
650 0 4 _aAnimals
650 0 4 _aBinding Sites
_xphysiology
650 0 4 _aBrain
_xmetabolism
650 0 4 _aCerebellum
_xmetabolism
650 0 4 _aExcitatory Amino Acid Antagonists
_xchemistry
650 0 4 _aHippocampus
_xmetabolism
650 0 4 _aMale
650 0 4 _aPyridines
_xchemistry
650 0 4 _aRats
650 0 4 _aRats, Sprague-Dawley
650 0 4 _aReceptor, Metabotropic Glutamate 5
650 0 4 _aReceptors, Metabotropic Glutamate
_xantagonists & inhibitors
650 0 4 _aThiazoles
_xchemistry
700 1 _aRao, Sara P
700 1 _aRowe, Blake
700 1 _aGiracello, Darlene R
700 1 _aHoltz, Greg
700 1 _aChapman, Deborah F
700 1 _aTehrani, Lida
700 1 _aBradbury, Margaret J
700 1 _aCosford, Nicholas D P
700 1 _aVarney, Mark A
773 0 _tThe Journal of pharmacology and experimental therapeutics
_gvol. 303
_gno. 3
_gp. 1044-51
856 4 0 _uhttps://doi.org/10.1124/jpet.102.040618
_zAvailable from publisher's website
999 _c12245281
_d12245281